Proactive Care Strategy Tested for Newly Diagnosed Type 2 Diabetes
Tests a more proactive care plan in adults newly diagnosed with type 2 diabetes.
Key facts
- Who runs it
- Kaiser Permanente
- Where
- Pleasanton, United StatesSee the site
- Trial code
- Registry title
- Population Health Management for KPNC Members With Newly Diagnosed Diabetes: A Randomized Trial of a Proactive and Augmented Initial Care Strategy
- Status
- Enrolling by invitation
- People taking part
- 204 people, planned
- Started
- Apr 2025
- Expected to end
- Jun 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Augmented Initial Type 2 Diabetes Care
- Record updated
- 2 April 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 74 who were recently diagnosed with type 2 diabetes and are Kaiser Permanente Northern California members. They also need a higher HbA1c at diagnosis.
- Age
- 18 to 74 years
- Sex
- All sexes can join.
- Disease stage
- Newly diagnosed type 2 diabetes. If age is 45 or younger, HbA1c must be above 8% (64 mmol/mol). If age is under 45, HbA1c must be above 10% (86 mmol/mol).
- Biomarker or test result
- HbA1c above 8% (64 mmol/mol) (age 45 or younger) or above 10% (age under 45), as written in the record.
Main reasons for not taking part
- Pregnant people
- People with likely type 1 diabetes
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Age 18-74 years
- Newly diagnosed with type 2 diabetes
- Kaiser Permanente Northern California member receiving care in a participating service area
- If age ≤45 years, then HbA1c>8%
- If age<45 years, then HbA1c>10%
Who cannot take part
- Individuals with likely type 1 diabetes (T1D)
- Individuals who are pregnant
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 74 years old?
Where in United States
- Kaiser Permanente-Division of ResearchPleasanton, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
This study is a 2-arm randomized trial of Augmented Initial Type 2 Diabetes (T2D) Care vs. Usual Initial T2D Care among adults (18-74 years) with newly diagnosed T2D who have risk factors (defined by age and diagnosis HbA1c value) for suboptimal early glycemic control. Augmented Initial T2D Care comprises the elements of usual care augmented by more proactive and intensive outreach from the diabetes care team. The study team will use electronic health record (EHR) data to assess between-arm differences in diabetes-related outcomes at 6- and 12 months.
The 2 groups in the trial
- Usual Initial Type 2 Diabetes (T2D) CareNo study treatment, for comparison
Patients in the usual care arm will receive the standard T2D care provided to Kaiser Permanente Northern California members with recently diagnosed T2D. This care includes any counseling or treatment recommendations made by the primary care provider and the assigned care manager.
- Augmented Initial Type 2 Diabetes (T2D) CareTreatment being tested
The intervention - Augmented Initial T2D Care - comprises the elements of usual care augmented by more proactive and intensive outreach from the diabetes care team and self-management support by care managers, health educators, and dieticians.
Treatment: Augmented Initial Type 2 Diabetes Care
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Population Health Management for Kaiser Permanente Northern California (KPNC) Members With Newly Diagnosed Diabetes: A Randomized Trial of a Proactive and Augmented Initial Care Strategy
- Plain-language title
- Proactive Care Strategy Tested for Newly Diagnosed Type 2 DiabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06906653, who can take part
- Record updated
- 2 April 2025